1. Novel therapeutic receptor agonists and antagonists in allergic conjunctivitis.
- Author
-
Abu SL, Hehar NK, and Chigbu DI
- Subjects
- Humans, Animals, Anti-Allergic Agents therapeutic use, Anti-Allergic Agents pharmacology, Toll-Like Receptors agonists, Toll-Like Receptors antagonists & inhibitors, Toll-Like Receptors immunology, Toll-Like Receptors metabolism, Histamine Antagonists therapeutic use, Conjunctivitis, Allergic drug therapy, Conjunctivitis, Allergic immunology
- Abstract
Purpose of Review: Allergic conjunctivitis is characterized by the development of pathophysiological changes to the ocular surface, which occurs when pro-allergic and pro-inflammatory mediators interact with their cognate receptors expressed on immune and nonimmune cells. Traditional treatments with antihistamines and corticosteroids provide relief, but there is a need for more efficacious and tolerable long-term therapy with a better safety profile. This article aims to provide an overview of the mode of action and clinical application of agonist therapies targeting glucocorticoid, melanocortin, and toll-like receptors, as well as antagonist therapies targeting cytokine, chemokine, integrin, and histamine receptors., Recent Findings: There has been considerable advancement in immunology and pharmacology, as well as a greater understanding of the cellular and molecular mechanisms of allergic conjunctivitis. Recent research advancing therapy for allergic conjunctivitis has focused on developing synthetic molecules and biologics that can interfere with the process of the allergic immune reaction., Summary: This review discusses novel therapeutic receptors being explored agonistically or antagonistically to develop alternative treatment options for allergic conjunctivitis. These novel approaches hold promise for improving the management of allergic eye diseases, offering patients hope for more effective and safer treatment options in the future., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF